This is the authors' abstract. We don't add key points for this paper.
Since their first report in 2000, tubulysins have sparked great interest for development as anti-cancer agents due to their exceptionally potent antiproliferative activity. Progress in the discovery and development of tubulysins, especially tubulysin conjugates, has quickly advanced despite limitations in their availability from Nature. In this Highlight, the key research on the isolation and structure determination, biosynthesis, bioactivity, structure-activity relationships (SAR), synthesis, and conjugates of tubulysins is presented.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Murray et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: